Mounting evidence indicates that serum soluble
E-cadherin (sE-
cadherin) serves as an important player in various physiological and
pathological processes. However, the crosstalk between serum sE-
cadherin and oxidative stress in
chronic hepatitis B (CHB) remains to be illustrated. The main purpose of this study is to explore the molecular mechanisms underlying the function of sE-
cadherin in CHB
virus infection. Levels of serum sE-
cadherin, total
antioxidant capacity (TAC),
glutathione (GSH),
superoxide dismutase (SOD), total
oxidant activity (TOA),
NADPH oxidase 2 (NOX2), and
malondialdehyde (MDA), from 51 patients with
hepatitis B envelope
antigen (
HBeAg)-negative CHB, 54 patients with
HBeAg-positive CHB, and 109 healthy individuals were detected by
enzyme-linked
immunosorbent assay. In our study, patients with CHB showed significantly higher serum sE-
cadherin levels than healthy individuals (P < .01). Furthermore, we also found that the serum sE-
cadherin levels were significantly negatively correlated with TAC,
antioxidant enzymes (GSH and SOD) in patients with CHB, and that serum sE-
cadherin concentrations were significantly positively correlated with liver
enzyme markers (
alanine transaminase and
aspartate aminotransferase) and oxidative markers (TOA, NOX2, and MDA) in patients with CHB. Therefore, serum sE-
cadherin may act as a new candidate
biomarker for reflecting
inflammation and oxidative stress status in the development and progression of
hepatitis B virus infection.